You just read:

First Patient Enrolled in the SMILE Study, Sensible Medical Innovation's Randomized Controlled Trial (RCT) Designed to Measure ReDS™ Technology Impact on Heart Failure Rehospitalizations

News provided by

Sensible Medical Innovations

Oct 20, 2015, 07:00 ET